Global Legal Chronicle: Rainmed Medical’s HK$146 Million IPO and Listing on the Hong Kong Stock Exchange
July 13, 2022
O’Melveny & Myers LLP represented Rainmed Medical Limited (2297.HK) in its IPO and listing on the Hong Kong Stock Exchange. The transaction marks O’Melveny’s 11th successful Chapter 18A Hong Kong IPO for biotech companies. The O’Melveny team was led by partners Ke Geng and Ke Zhu, with assistance from counsel Yazhe Liu and Xueyin Zhong, associates Stella Yang and Jingwei Huang, legal consultants Minhui Chen, Yirong Du, Elle Mei and Iris Su, paralegal Aileen Xu and trainee solicitor Jeffrey Hang. Partners Rob Plesnarski and Kurt Berney, counsel Billy Abbott and associate Dawn Lim provided tax and US legal opinion related advice.
Read the full article here.